Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders

Clinical trial NCT03344419 · SUSPENDED

Trial details

NCT number: NCT03344419
Sponsor: New York State Psychiatric Institute
Status: SUSPENDED
Phase: Phase 3
Study type: INTERVENTIONAL

Cocaine Use Disorder

Start date: 2017-10-01
Primary completion: 2024-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.